Haemato AG
Supplies specialty pharma and aesthetics products to pharmacies and clinics in DE & AT.
HAEK | F
Overview
Corporate Details
- ISIN(s):
- DE000A289VV1
- LEI:
- 529900Q3CGRYVCW7E340
- Country:
- Germany
- Address:
- Lilienthalstraße 3a, 12529 Schönefeld
- Website:
- https://haemato.de/en/start.html
- Sector:
- Wholesale and retail trade
- Industry:
- Wholesale of household goods
Description
Haemato AG is a specialty pharmaceutical company that supplies pharmacies, wholesalers, and clinics, primarily in Germany and Austria. The company operates through two core segments: Pharmaceuticals and Lifestyle & Aesthetics. The Pharmaceuticals division focuses on high-priced therapies for chronic diseases, with a portfolio of patent-protected medicines, biosimilars, generics, and narcotic pharmaceuticals (including cannabis products) in therapeutic areas such as oncology, HIV/AIDS, neurology, rheumatology, and ophthalmology. The Lifestyle & Aesthetics segment develops, manufactures, and distributes its own brands, including diagnostic tests and M1 SELECT cosmetics, in addition to supplying third-party products.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-04-10 00:00 |
Annual Report
Konzernabschluss zum Geschäftsjahr vom 01.01.2023 bis zum 31.12.2023
|
German | 314.8 KB | ||
| 2025-01-15 00:00 |
Annual / Quarterly Financial Statement
Jahresabschluss zum Geschäftsjahr vom 01.01.2023 bis zum 31.12.2023
|
German | 30.6 KB | ||
| 2024-09-26 00:00 |
Annual / Quarterly Financial Statement
Jahresabschluss zum Geschäftsjahr vom 01.01.2022 bis zum 31.12.2022
|
German | 56.0 KB | ||
| 2024-02-09 00:00 |
Annual Report
Konzernabschluss zum Geschäftsjahr vom 01.01.2022 bis zum 31.12.2022
|
German | 343.3 KB | ||
| 2023-12-12 00:00 |
Annual / Quarterly Financial Statement
Jahresabschluss zum Geschäftsjahr vom 01.01.2021 bis zum 31.12.2021
|
German | 61.5 KB | ||
| 2023-11-30 14:14 |
Delisting Announcement
HAEMATO AG: Termination of listing in the Open Market
|
English | 8.7 KB | ||
| 2023-11-16 08:21 |
Earnings Release
HAEMATO AG publishes figures for the third quarter of 2023: Sales increase o…
|
English | 15.5 KB | ||
| 2023-11-15 19:42 |
Regulatory News Service
Termination of the botulinum toxin project
|
English | 8.1 KB | ||
| 2023-10-30 00:00 |
Interim Report
Half-yearly financial statements 2023
|
English | 1.8 MB | ||
| 2023-10-30 00:00 |
Interim Report
Half-yearly financial statements 2023
|
English | 1.8 MB | ||
| 2023-08-31 09:00 |
Earnings Release
HAEMATO AG publishes figures for the first half of 2023
|
English | 9.7 KB | ||
| 2023-06-09 00:00 |
Annual Report
Annual financial statements 2022
|
English | 5.9 MB | ||
| 2023-06-09 00:00 |
Annual Report
Annual financial statements 2022
|
English | 5.9 MB | ||
| 2023-05-31 16:34 |
Earnings Release
HAEMATO AG with a strong start into the year 2023: Revenue increase of over 2…
|
English | 8.6 KB | ||
| 2023-05-16 17:40 |
Notice of Dividend Amount
HAEMATO AG: Dividend of EUR 1.20
|
English | 5.7 KB |
Automate Your Workflow. Get a real-time feed of all Haemato AG filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Haemato AG
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Haemato AG via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
